|
Boston Globe online and Daily News Update newsletter Solace Pharmaceuticals said today it raised $15 million and named Pfizer Inc. veteran Eliot Forster as its chief executive. Solace of Boston seeks to develop innovative therapies for treating chronic pain. The company said today it raised $15 million in Series A financing in a round co-led by venture capital firms Polaris Venture Partners, with offices in Waltham and Seattle, and InterWest Partners, which has offices in California and Texas, Solace said. Forster was most recently Pfizer's head of development for Europe and Asia, Solace said. |
Latest NewsSolace's Chemistry Advisory Board members featured05 February 2008 Solace Pharmaceuticals names two new senior team members 04 February 2008 Emerging Company Profile - Solace: Comfort in (Pain) Research, BioCentury 09 July 2007 Solace ready to go global in two continents with $15M in VC, to begin treatment tests for chronic pain 25 May 2007 Solace Pharmaceuticals (Boston) - Eliot Forster was named chief executive with this developer of therapeutics .. 05 May 2007 Start-Up Solace Raises $15M In Series A For Pain Drugs 02 May 2007 Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO 01 May 2007 Pain Gain: Drug startup developing new approach to chronic pain 01 May 2007 Solace Pharmaceuticals launches with $15M in VC 01 May 2007 Solace Pharma raises $15m 01 May 2007 Solace Raises $15M For New Pain Treatments 01 May 2007 Solace raises $15 million, names CEO 01 May 2007 |